Skip to main content
Top
Published in:

01-03-2025 | Inflammatory Rheumatic Diseases | Review

Thyroid disease as a comorbidity in inflammatory rheumatic diseases

Authors: Yuliya Fedorchenko, Marlen Yessirkepov, Bohdana Doskaliuk, Liubomyr Zaiats, Khaiyom Mahmudov

Published in: Rheumatology International | Issue 3/2025

Login to get access

Abstract

Thyroid disease is a common comorbidity in inflammatory rheumatic diseases (IRDs). It complicates disease management and treatment of IRDs. The interplay between thyroid disfunction and IRDs is confounded by shared autoimmune mechanisms and systemic inflammation. Available evidence suggests that rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc) are associated with an elevated risk of hypothyroidism, hyperthyroidism, and autoimmune thyroid disease (AITD). This review explores mechanisms of thyroid disease in IRDs, overviews implications for disease management, and highlights approaches to optimal patient outcomes. Recent studies point to the need for routine thyroid screening in high-risk IRD populations and justify therapies with anti-TNF-α and anti-IL-17 agents, targeting both thyroid disease and IRDs. This integrated management strategy is crucial for optimizing therapeutic approaches in overlapping autoimmune conditions.
Literature
1.
go back to reference Li Q, Wang B, Mu K, Zhang J, Yang Y, Yao W, Zhu J, Zhang JA (2019) Increased risk of thyroid dysfunction among patients with rheumatoid arthritis. Front Endocrinol (Lausanne) 9:799. https://doi.org/10.3389/fendo.2018.00799PubMedCrossRef Li Q, Wang B, Mu K, Zhang J, Yang Y, Yao W, Zhu J, Zhang JA (2019) Increased risk of thyroid dysfunction among patients with rheumatoid arthritis. Front Endocrinol (Lausanne) 9:799. https://​doi.​org/​10.​3389/​fendo.​2018.​00799PubMedCrossRef
2.
go back to reference Cárdenas Roldán J, Amaya-Amaya J, Castellanos-de la Hoz J, Giraldo-Villamil J, Montoya-Ortiz G, Cruz-Tapias P, Rojas-Villarraga A, Mantilla RD, Anaya JM (2012) Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis 2012:864907 https://doi.org/10.1155/2012/864907 Cárdenas Roldán J, Amaya-Amaya J, Castellanos-de la Hoz J, Giraldo-Villamil J, Montoya-Ortiz G, Cruz-Tapias P, Rojas-Villarraga A, Mantilla RD, Anaya JM (2012) Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis 2012:864907 https://​doi.​org/​10.​1155/​2012/​864907
5.
go back to reference Yao Q, Song Z, Wang B, Zhang JA, Mu K (2019) Thyroid disorders in patients with systemic sclerosis: a systematic review and meta-analysis. Autoimmun Rev 18(6):634–636PubMedCrossRef Yao Q, Song Z, Wang B, Zhang JA, Mu K (2019) Thyroid disorders in patients with systemic sclerosis: a systematic review and meta-analysis. Autoimmun Rev 18(6):634–636PubMedCrossRef
16.
go back to reference Jones D, Anjanappa JC, Hiremath S, Siddaraju A, Hanumantha Reddy CK, Sampoornam SA et al (2021) The prevalence of thyroid dysfunction in patients with connective tissue disorders. Asian J Med Sci 12(7):33–36.CrossRef Jones D, Anjanappa JC, Hiremath S, Siddaraju A, Hanumantha Reddy CK, Sampoornam SA et al (2021) The prevalence of thyroid dysfunction in patients with connective tissue disorders. Asian J Med Sci 12(7):33–36.CrossRef
17.
21.
go back to reference Peng Z, Huang W, Tang M, Chen B, Yang R, Liu Q et al (2024) Investigating the shared genetic architecture between hypothyroidism and rheumatoid arthritis. Front Immunol 14:1286491PubMedPubMedCentralCrossRef Peng Z, Huang W, Tang M, Chen B, Yang R, Liu Q et al (2024) Investigating the shared genetic architecture between hypothyroidism and rheumatoid arthritis. Front Immunol 14:1286491PubMedPubMedCentralCrossRef
22.
go back to reference Liu X, Yuan J, Wang X et al (2024) Association between rheumatoid arthritis and autoimmune thyroid disease: evidence from complementary genetic methods. Endocrine 84:171–178PubMedCrossRef Liu X, Yuan J, Wang X et al (2024) Association between rheumatoid arthritis and autoimmune thyroid disease: evidence from complementary genetic methods. Endocrine 84:171–178PubMedCrossRef
23.
go back to reference Yazdanifar MA, Bagherzadeh-Fard M, Habibi MA, Vahedian M, Bagherzadeh M, Masoumi M (2023) The association between thyroid dysfunction, autoimmune thyroid disease, and rheumatoid arthritis disease severity. BMC Endocr Disord 23(1):212PubMedPubMedCentralCrossRef Yazdanifar MA, Bagherzadeh-Fard M, Habibi MA, Vahedian M, Bagherzadeh M, Masoumi M (2023) The association between thyroid dysfunction, autoimmune thyroid disease, and rheumatoid arthritis disease severity. BMC Endocr Disord 23(1):212PubMedPubMedCentralCrossRef
24.
go back to reference McCoy SS, Crowson CS, Gabriel SE, Matteson EL (2012) Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol 39(5):954–958PubMedPubMedCentralCrossRef McCoy SS, Crowson CS, Gabriel SE, Matteson EL (2012) Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol 39(5):954–958PubMedPubMedCentralCrossRef
25.
go back to reference Agca R, Heslinga M, Raterman HG, Simsek S, Voskuyl AE, Nurmohamed MT (2021) Coexistent subclinical hypothyroidism is associated with an increased risk of new cardiovascular events in rheumatoid arthritis: an explorative study. Scand J Rheumatol 50(6):441–444PubMedCrossRef Agca R, Heslinga M, Raterman HG, Simsek S, Voskuyl AE, Nurmohamed MT (2021) Coexistent subclinical hypothyroidism is associated with an increased risk of new cardiovascular events in rheumatoid arthritis: an explorative study. Scand J Rheumatol 50(6):441–444PubMedCrossRef
26.
go back to reference Chodara AM, Wattiaux A, Bartels CM (2017) Managing cardiovascular disease risk in rheumatoid arthritis: clinical updates and three strategic approaches. Curr Rheumatol Rep 19(4):16PubMedPubMedCentralCrossRef Chodara AM, Wattiaux A, Bartels CM (2017) Managing cardiovascular disease risk in rheumatoid arthritis: clinical updates and three strategic approaches. Curr Rheumatol Rep 19(4):16PubMedPubMedCentralCrossRef
27.
go back to reference Karstensen JK, Bremander A, Christensen JR, Primdahl J (2024) Participation in cardiovascular screening consultations, the who, when and why - a cohort study on patients with rheumatoid arthritis. BMC Rheumatol 8(1):8PubMedPubMedCentralCrossRef Karstensen JK, Bremander A, Christensen JR, Primdahl J (2024) Participation in cardiovascular screening consultations, the who, when and why - a cohort study on patients with rheumatoid arthritis. BMC Rheumatol 8(1):8PubMedPubMedCentralCrossRef
28.
go back to reference Ni J, Li J, Wang Y, Guan L, Lin H, Zhang L, Zhang H (2022) Systemic lupus erythematosus patients with related organ damage are at high risk of hypothyroidism. Front Endocrinol (Lausanne) 13:920283PubMedCrossRef Ni J, Li J, Wang Y, Guan L, Lin H, Zhang L, Zhang H (2022) Systemic lupus erythematosus patients with related organ damage are at high risk of hypothyroidism. Front Endocrinol (Lausanne) 13:920283PubMedCrossRef
29.
go back to reference Athanassiou L, Kostoglou-Athanassiou I, Kaiafa G, Tsakiridis P, Koukosias N, Mitsoulis S, Savopoulos C, Athanassiou P (2023) Thyroid disease and systemic lupus erythematosus. Med (Kaunas) 59(11):1911 Athanassiou L, Kostoglou-Athanassiou I, Kaiafa G, Tsakiridis P, Koukosias N, Mitsoulis S, Savopoulos C, Athanassiou P (2023) Thyroid disease and systemic lupus erythematosus. Med (Kaunas) 59(11):1911
30.
go back to reference Rasaei N, Shams M, Kamali-Sarvestani E, Nazarinia MA (2015) The prevalence of thyroid dysfunction in patients with systemic Lupus Erythematosus. Iran Red Crescent Med J 17(12):e17298PubMedPubMedCentralCrossRef Rasaei N, Shams M, Kamali-Sarvestani E, Nazarinia MA (2015) The prevalence of thyroid dysfunction in patients with systemic Lupus Erythematosus. Iran Red Crescent Med J 17(12):e17298PubMedPubMedCentralCrossRef
31.
go back to reference Luo W, Mao P, Zhang L, Yang Z (2018) Association between systemic lupus erythematosus and thyroid dysfunction: a meta-analysis. Lupus 27(13):2120–2128PubMedCrossRef Luo W, Mao P, Zhang L, Yang Z (2018) Association between systemic lupus erythematosus and thyroid dysfunction: a meta-analysis. Lupus 27(13):2120–2128PubMedCrossRef
32.
go back to reference Domingues SL, Gonçalves FT, Jorge MLMP, Limongi JE, Ranza R, Jorge PT (2017) High prevalence of hypothyroidism in systemic lupus erythematosus patients without an increase in circulating anti-thyroid antibodies. Endocr Pract 23(11):1304–1310PubMedCrossRef Domingues SL, Gonçalves FT, Jorge MLMP, Limongi JE, Ranza R, Jorge PT (2017) High prevalence of hypothyroidism in systemic lupus erythematosus patients without an increase in circulating anti-thyroid antibodies. Endocr Pract 23(11):1304–1310PubMedCrossRef
33.
go back to reference Li J, Wang X, Xie T, Lin W, Yang H, Li T, Xu K, Zhang B, Qu X, Zhang H, Ning W, Liu S, Li T, Zuo X, Liu S, Zhang W (2021) Hypothyroidism and its association with systemic lupus erythematosus: a cross-sectional study in Chinese patients. Am J Med Sci 361(1):63–68PubMedCrossRef Li J, Wang X, Xie T, Lin W, Yang H, Li T, Xu K, Zhang B, Qu X, Zhang H, Ning W, Liu S, Li T, Zuo X, Liu S, Zhang W (2021) Hypothyroidism and its association with systemic lupus erythematosus: a cross-sectional study in Chinese patients. Am J Med Sci 361(1):63–68PubMedCrossRef
34.
go back to reference Yun JS, Bae JM, Kim KJ, Jung YS, Kim GM, Kim HR, Lee JS, Ko SH, Cha SA, Ahn YB (2017) Increased risk of thyroid diseases in patients with systemic lupus erythematosus: a nationwide population-based study in Korea. PLoS ONE 12(6):e0179088PubMedPubMedCentralCrossRef Yun JS, Bae JM, Kim KJ, Jung YS, Kim GM, Kim HR, Lee JS, Ko SH, Cha SA, Ahn YB (2017) Increased risk of thyroid diseases in patients with systemic lupus erythematosus: a nationwide population-based study in Korea. PLoS ONE 12(6):e0179088PubMedPubMedCentralCrossRef
35.
go back to reference AL-Homood IA, Alkhathami RA, Alenazi SK et al (2022) Thyroid dysfunction among patients with systemic lupus erythematosus in Saudi Arabia. Dr Sulaiman Al Habib Med J 4:169–173CrossRef AL-Homood IA, Alkhathami RA, Alenazi SK et al (2022) Thyroid dysfunction among patients with systemic lupus erythematosus in Saudi Arabia. Dr Sulaiman Al Habib Med J 4:169–173CrossRef
36.
go back to reference Liu YC, Lin WY, Tsai MC, Fu LS (2019) Systemic lupus erythematosus and thyroid disease - experience in a single medical center in Taiwan. J Microbiol Immunol Infect 52(3):480–486PubMedCrossRef Liu YC, Lin WY, Tsai MC, Fu LS (2019) Systemic lupus erythematosus and thyroid disease - experience in a single medical center in Taiwan. J Microbiol Immunol Infect 52(3):480–486PubMedCrossRef
37.
go back to reference Lin WY, Chang CL, Fu LS, Lin CH, Lin HK (2015) Systemic lupus erythematosus and thyroid disease: a 10-year study. J Microbiol Immunol Infect 48(6):676–683PubMedCrossRef Lin WY, Chang CL, Fu LS, Lin CH, Lin HK (2015) Systemic lupus erythematosus and thyroid disease: a 10-year study. J Microbiol Immunol Infect 48(6):676–683PubMedCrossRef
38.
go back to reference Meridor K, Rotman-Pikielny P, Carmi O, Werner M, Levy Y (2022) Thyroid disorders in patients with systemic sclerosis: biochemical and sonographic characteristics. Isr Med Assoc J 24(11):732–736PubMed Meridor K, Rotman-Pikielny P, Carmi O, Werner M, Levy Y (2022) Thyroid disorders in patients with systemic sclerosis: biochemical and sonographic characteristics. Isr Med Assoc J 24(11):732–736PubMed
39.
go back to reference Toki S, Motegi S, Yamada K, Uchiyama A, Ishikawa O (2014) Demographic and clinical features of autoimmune thyroid disorder in Japanese patients with systemic sclerosis. J Dermatol 41(12):1053–1057PubMedCrossRef Toki S, Motegi S, Yamada K, Uchiyama A, Ishikawa O (2014) Demographic and clinical features of autoimmune thyroid disorder in Japanese patients with systemic sclerosis. J Dermatol 41(12):1053–1057PubMedCrossRef
40.
go back to reference Paolee Y, Foocharoen C, Charoensri S, Mayxay M, Mahakkanukrauh A, Suwannaroj S, Nanagara R (2021) The prevalence and clinical features associated with hypothyroidism among Thai systemic sclerosis patients. Sci Rep 11(1):14902PubMedPubMedCentralCrossRef Paolee Y, Foocharoen C, Charoensri S, Mayxay M, Mahakkanukrauh A, Suwannaroj S, Nanagara R (2021) The prevalence and clinical features associated with hypothyroidism among Thai systemic sclerosis patients. Sci Rep 11(1):14902PubMedPubMedCentralCrossRef
41.
go back to reference Singh PK, Sharma SK, Sinha A, Dutta P (2016) Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West India. Clin Rheumatol 35(3):765–769PubMedCrossRef Singh PK, Sharma SK, Sinha A, Dutta P (2016) Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West India. Clin Rheumatol 35(3):765–769PubMedCrossRef
42.
go back to reference Akuka A, Watad A, Comaneshter D, Cohen AD, Amital H, Bragazzi NL (2019) Systemic sclerosis patients are at higher risk of hyperthyroidism and have a worse survival than those without hyperthyroidism: a nationwide population-based cohort study. Eur J Clin Invest 49(12):e13177PubMedCrossRef Akuka A, Watad A, Comaneshter D, Cohen AD, Amital H, Bragazzi NL (2019) Systemic sclerosis patients are at higher risk of hyperthyroidism and have a worse survival than those without hyperthyroidism: a nationwide population-based cohort study. Eur J Clin Invest 49(12):e13177PubMedCrossRef
43.
go back to reference Emmungil H, Erdogan M, Kalfa M, Karabulut G, Kocanaogulları H, Inal V, Aksu K, Oksel F, Kabasakal Y, Keser G (2014) Autoimmune thyroid disease in ankylosing spondylitis. Clin Rheumatol 33(7):955–961PubMedCrossRef Emmungil H, Erdogan M, Kalfa M, Karabulut G, Kocanaogulları H, Inal V, Aksu K, Oksel F, Kabasakal Y, Keser G (2014) Autoimmune thyroid disease in ankylosing spondylitis. Clin Rheumatol 33(7):955–961PubMedCrossRef
44.
go back to reference Vastarella M, Megna M, Lupoli GA, Napolitano M, Gallo L, Balato A, Tasso M, Costa L, Fabbrocini G, Peluso R (2021) Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? Australas J Dermatol 62(2):e207–e211PubMedCrossRef Vastarella M, Megna M, Lupoli GA, Napolitano M, Gallo L, Balato A, Tasso M, Costa L, Fabbrocini G, Peluso R (2021) Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? Australas J Dermatol 62(2):e207–e211PubMedCrossRef
45.
go back to reference Wang SH, Wang J, Lin YS, Tung TH, Chi CC (2019) Increased risk for incident thyroid diseases in people with psoriatic disease: a cohort study. J Am Acad Dermatol 80(4):1006–1012PubMedCrossRef Wang SH, Wang J, Lin YS, Tung TH, Chi CC (2019) Increased risk for incident thyroid diseases in people with psoriatic disease: a cohort study. J Am Acad Dermatol 80(4):1006–1012PubMedCrossRef
46.
go back to reference Du J, Ma C, Wang R, Lin L, Gao L, Chen S, Lu X (2021) Relationship between different psoriasis types and thyroid dysfunction: a retrospective analysis. Scanning 2021:1834556 Du J, Ma C, Wang R, Lin L, Gao L, Chen S, Lu X (2021) Relationship between different psoriasis types and thyroid dysfunction: a retrospective analysis. Scanning 2021:1834556
48.
go back to reference Xu J, Wang B, Li Q, Yao Q, Jia X, Song R, Zhang JA (2019) Risk of Thyroid Disorders in Patients with Gout and Hyperuricemia (2019) Horm Metab Res 51(8):522–530 Xu J, Wang B, Li Q, Yao Q, Jia X, Song R, Zhang JA (2019) Risk of Thyroid Disorders in Patients with Gout and Hyperuricemia (2019) Horm Metab Res 51(8):522–530
50.
go back to reference Chao G, Zhu Y, Fang L (2019) Retrospective Analysis of the Correlation between Uric Acid and Thyroid Hormone in People with Normal Thyroid Function. J Diabetes Res 2019:5904264 Chao G, Zhu Y, Fang L (2019) Retrospective Analysis of the Correlation between Uric Acid and Thyroid Hormone in People with Normal Thyroid Function. J Diabetes Res 2019:5904264
51.
go back to reference Huang Y, Li Z, Yang K, Zhang L, Wei C, Yang P et al (2022) The association of uric acid with the development of thyroid nodules: a retrospective cohort study. BMC Endocr Disord 22(1):197PubMedPubMedCentralCrossRef Huang Y, Li Z, Yang K, Zhang L, Wei C, Yang P et al (2022) The association of uric acid with the development of thyroid nodules: a retrospective cohort study. BMC Endocr Disord 22(1):197PubMedPubMedCentralCrossRef
52.
go back to reference Choi W, Yang YS, Chang DJ, Chung YW, Kim H, Ko S et al (2021) Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level. Sci Rep 11(1):20305PubMedPubMedCentralCrossRef Choi W, Yang YS, Chang DJ, Chung YW, Kim H, Ko S et al (2021) Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level. Sci Rep 11(1):20305PubMedPubMedCentralCrossRef
53.
go back to reference Zadeh N, Getzug T, Grody W (2011) Diagnosis and management of familial Mediterranean fever: integrating medical genetics in a dedicated interdisciplinary clinic. Genet Med 13:263–269PubMedCrossRef Zadeh N, Getzug T, Grody W (2011) Diagnosis and management of familial Mediterranean fever: integrating medical genetics in a dedicated interdisciplinary clinic. Genet Med 13:263–269PubMedCrossRef
54.
go back to reference Dikbas O, Soy M, Bes C, Ankaralı H, Bugdayci G, Zeyrek A (2013) Thyroid autoimmunity in patients with familial Mediterranean Fever: preliminary results. Eur Rev Med Pharmacol Sci 17(22):3024–3030PubMed Dikbas O, Soy M, Bes C, Ankaralı H, Bugdayci G, Zeyrek A (2013) Thyroid autoimmunity in patients with familial Mediterranean Fever: preliminary results. Eur Rev Med Pharmacol Sci 17(22):3024–3030PubMed
56.
go back to reference Ciğerli O, Unal AD, Parıldar H, Demiralay E, Tarçın O (2014) Amyloid goiter due to familial mediterranean fever in a patient with byler syndrome: a case report. Balkan Med J 31(3):261–263PubMedPubMedCentralCrossRef Ciğerli O, Unal AD, Parıldar H, Demiralay E, Tarçın O (2014) Amyloid goiter due to familial mediterranean fever in a patient with byler syndrome: a case report. Balkan Med J 31(3):261–263PubMedPubMedCentralCrossRef
59.
go back to reference López-Muñoz B, Greco Bermúdez L, Marín-Jiménez D et al (2019) An Unusual Amyloid Goiter in a 48-Year-Old Woman with Rheumatoid Arthritis, Secondary Amyloidosis and Renal Failure. Case Rep Endocrinol 2019:4291486 López-Muñoz B, Greco Bermúdez L, Marín-Jiménez D et al (2019) An Unusual Amyloid Goiter in a 48-Year-Old Woman with Rheumatoid Arthritis, Secondary Amyloidosis and Renal Failure. Case Rep Endocrinol 2019:4291486
61.
go back to reference Lari E, Burhamah W, Lari A, Alsafran S, Ismail A (2020) Amyloid goiter - A rare case report and literature review. Ann Med Surg (Lond) 57:295–298PubMedCrossRef Lari E, Burhamah W, Lari A, Alsafran S, Ismail A (2020) Amyloid goiter - A rare case report and literature review. Ann Med Surg (Lond) 57:295–298PubMedCrossRef
64.
go back to reference Park SK, Ryoo JH, Kim MH, Jung JY, Kim KN, Shin S et al (2024) Association between eight autoimmune diseases and thyroid Cancer: a Nationwide Cohort Study. Thyroid: Official J Am Thyroid Association 34(2):206–214CrossRef Park SK, Ryoo JH, Kim MH, Jung JY, Kim KN, Shin S et al (2024) Association between eight autoimmune diseases and thyroid Cancer: a Nationwide Cohort Study. Thyroid: Official J Am Thyroid Association 34(2):206–214CrossRef
65.
go back to reference Zhang M, Li XM, Wang GS, Qian L, Tao JH, Ma Y et al (2014) Thyroid cancer in systemic lupus erythematosus: a meta analysis. Int J Clin Exp Pathol 7(9):6270–6273PubMedPubMedCentral Zhang M, Li XM, Wang GS, Qian L, Tao JH, Ma Y et al (2014) Thyroid cancer in systemic lupus erythematosus: a meta analysis. Int J Clin Exp Pathol 7(9):6270–6273PubMedPubMedCentral
66.
go back to reference Kawano Y, Nambu M, Uejima Y, Sato S, Suganuma E, Takano T et al (2017) Risk factors for thyroid Cancer in systemic Lupus Erythematosus. Global Pediatr Health 4:2333794X17736700CrossRef Kawano Y, Nambu M, Uejima Y, Sato S, Suganuma E, Takano T et al (2017) Risk factors for thyroid Cancer in systemic Lupus Erythematosus. Global Pediatr Health 4:2333794X17736700CrossRef
67.
go back to reference Terlemez R, Akgün K, Palamar D, Boz S, Sarı H (2017) The clinical importance of the thyroid nodules during anti-tumor necrosis factor therapy in patients with axial spondyloarthritis. Clin Rheumatol 36(5):1071–1076PubMedCrossRef Terlemez R, Akgün K, Palamar D, Boz S, Sarı H (2017) The clinical importance of the thyroid nodules during anti-tumor necrosis factor therapy in patients with axial spondyloarthritis. Clin Rheumatol 36(5):1071–1076PubMedCrossRef
68.
go back to reference Fukui S, Ikeda Y, Kataoka Y, Yanaoka H, Tamaki H, Tsuda T et al (2021) Clinical significance of monitoring hypothyroidism in patients with autoimmune rheumatic disease: a retrospective cohort study. Sci Rep 11(1):13851PubMedPubMedCentralCrossRef Fukui S, Ikeda Y, Kataoka Y, Yanaoka H, Tamaki H, Tsuda T et al (2021) Clinical significance of monitoring hypothyroidism in patients with autoimmune rheumatic disease: a retrospective cohort study. Sci Rep 11(1):13851PubMedPubMedCentralCrossRef
69.
go back to reference Bengtsson C, Padyukov L, Källberg H, Saevarsdottir S (2014) Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study. Ann Rheum Dis 73(6):1096–1100PubMedCrossRef Bengtsson C, Padyukov L, Källberg H, Saevarsdottir S (2014) Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study. Ann Rheum Dis 73(6):1096–1100PubMedCrossRef
70.
go back to reference Waldenlind K, Delcoigne B, Saevarsdottir S, Askling J (2024) Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritis. J Intern Med 295(3):313–321PubMedCrossRef Waldenlind K, Delcoigne B, Saevarsdottir S, Askling J (2024) Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritis. J Intern Med 295(3):313–321PubMedCrossRef
71.
go back to reference Kaklamanos M, Thomas D, Pikazis D, Kaltsas G (2015) Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseases. Endocrine 50(1):146–153PubMedCrossRef Kaklamanos M, Thomas D, Pikazis D, Kaltsas G (2015) Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseases. Endocrine 50(1):146–153PubMedCrossRef
72.
go back to reference Bracewell C, Vila J, Narayanan K, Kelly C (2009) Common ground: the overlap between Endocrinology and Rheumatology. Eur J Intern Med 20(6):569–571PubMedCrossRef Bracewell C, Vila J, Narayanan K, Kelly C (2009) Common ground: the overlap between Endocrinology and Rheumatology. Eur J Intern Med 20(6):569–571PubMedCrossRef
Metadata
Title
Thyroid disease as a comorbidity in inflammatory rheumatic diseases
Authors
Yuliya Fedorchenko
Marlen Yessirkepov
Bohdana Doskaliuk
Liubomyr Zaiats
Khaiyom Mahmudov
Publication date
01-03-2025

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more